Role of salvage radical prostatectomy for recurrent prostate cancer after radiation therapy

Journal of Clinical Oncology

Volumn 23, Issue 32, 2005, Pages 8198-8203

  Stephenson, Andrew J ^a   Eastham, James A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

CANCER RADIOTHERAPY; CRYOTHERAPY; DIAGNOSTIC TEST; DISEASE COURSE; HUMAN; INTERMETHOD COMPARISON; MEDICAL SOCIETY; MINIMALLY INVASIVE SURGERY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; PROTEIN BLOOD LEVEL; RECURRENT CANCER; REVIEW; SALVAGE THERAPY; SENSITIVITY AND SENSIBILITY; URETHRA STRICTURE; URINE INCONTINENCE; BRACHYTHERAPY; MALE; METABOLISM; PROSTATE TUMOR; TUMOR RECURRENCE; UNITED STATES;

BRACHYTHERAPY; CRYOTHERAPY; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; SALVAGE THERAPY; TUMOR MARKERS, BIOLOGICAL; UNITED STATES;

EID: 33644672652     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.03.1468     Document Type: Review

References (45)

1. Jemal A, Murray T, Ward E, et al: Cancer statistics, 2005. CA Cancer J Clin 55:10-30, 2005
2. Moul JW: Prostate specific antigen only progression of prostate cancer. J Urol 163:1632-1642, 2000
3. Lee WR, Hanks GE, Hanlon A: Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: Cinical observations. J Clin Oncol 15:230-238, 1997
4. D'Amico AV, Cote K, Loffredo M, et al: Determinants of prostate cancer-specific survival after radiation therapy for patients with clinically localized prostate cancer. J Clin Oncol 20:4567-4573, 2002
5. Pinover WH, Horwitz EM, Hanlon AL, et al: Validation of a treatment policy for patients with prostate specific antigen failure after three-dimensional conformal prostate radiation therapy. Cancer 97:1127-1133, 2003
6. Grossfeld GD, Li YP, Lubeck DP, et al: Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: Data from cancer of the prostate strategic urologic research endeavor. J Urol 168:530-535, 2002
7. Cox JD, Gallagher MJ, Hammond EH, et al: Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy: American Society for Therapeutic Radiology and Oncology Consensus Panel. J Clin Oncol 17:1155, 1999
8. Crook JM, Bahadur YA, Bociek RG, et al: Radiotherapy for localized prostate carcinoma: The correlation of pretreatment prostate specific antigen and nadir prostate specific antigen with outcome as assessed by systematic biopsy and serum prostate specific antigen. Cancer 79:328-336, 1997
9. Pollack A, Zagars GK, Antolak JA, et al: Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: Analysis of a prostate cancer randomized radiation dose escalation trial. Int J Radiat Oncol Biol Phys 54:677-685, 2002
10. Zelefsky MJ, Leibel SA, Gaudin PB, et al: Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 41:491-500, 1998
11. Zagars GK, Pollack A, von Eschenbach AC: Prostate cancer and radiation therapy: The message conveyed by serum prostate-specific antigen. Int J Radiat Oncol Biol Phys 33:23-35, 1995
12. Kaplan ID, Prestidge BR, Bagshaw MA, et al: The importance of local control in the treatment of prostatic cancer. J Urol 147:917-921, 1992
13. Fuks Z, Leibel SA, Wallner KE, et al: The effect of local control on metastatic dissemination in carcinoma of the prostate: Long-term results in patients treated with 1251 implantation. Int J Radiat Oncol Biol Phys 21:537-547, 1991
14. Holzman M, Carlton CE Jr, Scardino PT: The frequency and morbidity of local tumor recurrence after definitive radiotherapy for stage C prostate cancer. J Urol 146:1578-1582, 1991
15. Bianco FJ Jr, Scardino PT, Stephenson AJ, et al: Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Int J Radiat Oncol Biol Phys 62:448-453, 2005
16. Amling CL, Lerner SE, Martin SK, et al: Deoxyribonucleic acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancer. J Urol 161:857-863, 1999
17. Izawa JI, Madsen LT, Scott SM, et al: Salvage cryotherapy for recurrent prostate cancer after radiotherapy: Variables affecting patient outcome. J Clin Oncol 20:2664-2671, 2002
18. Rogers E, Ohori M, Kassabian VS, et al: Salvage radical prostatectomy: Outcome measured by serum prostate specific antigen levels. J Urol 153:104-110, 1995
19. Brenner PC, Russo P, Wood DP, et al: Salvage radical prostatectomy in the management of locally recurrent prostate cancer after 1251 implantation. Br J Urol 75:44-47, 1995
20. Gheiler EL, Tefilli MV, Tiguert R, et al: Predictors for maximal outcome in patients undergoing salvage surgery for radio-recurrent prostate cancer. Urology 51:789-795, 1998
21. Link P, Freiha FS: Radical prostatectomy after definitive radiation therapy for prostate cancer. Urology 37:189-192, 1991
22. Moul JW, Paulson DF: The role of radical surgery in the management of radiation recurrent and large volume prostate cancer. Cancer 68:1265-1271, 1991
23. Pontes JE, Montie J, Klein E, et al: Salvage surgery for radiation failure in prostate cancer. Cancer 71:976-980, 1993
24. Stein A, Smith RB, deKernion JB: Salvage radical prostatectomy after failure of curative radiotherapy for adenocarcinoma of prostate. Urology 40:197-200, 1992
25. Hanlon AL, Pinover WH, Horwitz EM, et al: Patterns and fate of PSA bouncing following 3D-CRT. Int J Radiat Oncol Biol Phys 50:845-849, 2001
26. Rosser CJ, Kuban DA, Levy LB, et al: Prostate specific antigen bounce phenomenon after external beam radiation for clinically localized prostate cancer. J Urol 168:2001-2005, 2002
27. Consensus statement: Guidelines for PSA following radiation therapy: American Society for Therapeutic Radiology and Oncology Consensus Panel. Int J Radiat Oncol Biol Phys 37:1035-1041, 1997
28. Kuban DA, Thames HD, Levy LB, et al: Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era. Int J Radiat Oncol Biol Phys 57:915-928, 2003
29. Shipley WU, Thames HD, Sandler HM, et al: Radiation therapy for clinically localized prostate cancer: A multi-institutional pooled analysis. JAMA 281:1598-1604, 1999
30. Stephenson AJ, Scardino PT, Eastham JA, et al: Defining biochemical recurrence of prostate cancer after radical prostatectomy: A proposal for a standardized definition. J Urol 173:183, abstract 671, 2005
31. Stephenson AJ, Scardino PT, Bianco FJ Jr, et al: Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy. J Urol 172:2239-2243, 2004
32. Crook JM, Perry GA, Robertson S, et al: Routine prostate biopsies following radiotherapy for prostate cancer: results for 226 patients. Urol 45:624-632, 1995
33. Stephenson AJ, Shariat SF, Zelefsky MJ, et al: Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. JAMA 291:1325-1332, 2004
34. Kuban DA, Thames HD, Shipley WU: Defining recurrence after radiation for prostate cancer. J Urol 173:1871-1878, 2005
35. Ward JF, Sebo TJ, Blute ML, et al: Salvage surgery for radiorecurrent prostate cancer: contemporary outcomes. J Urol 173:1156-1160, 2005
36. Chin JL, Pautler SE, Mouraviev V, et al: Results of salvage cryoablation of the prostate after radiation: identifying predictors of treatment failure and complications. J Urol 165:1937-1942, 2001
37. Ghafar MA, Johnson CW, De La Taille A, et al: Salvage cryotherapy using an argon based system for locally recurrent prostate cancer after radiation therapy: The Columbia experience. J Urol 166:1333-1338, 2001
38. Beyer DC: Permanent brachytherapy as salvage treatment for recurrent prostate cancer. Urology 54:880-883, 1999
39. Grado GL, Collins JM, Kriegshauser JS, et al: Salvage brachytherapy for localized prostate cancer after radiotherapy failure. Urology 53:2-10, 1999
40. Lerner SE, Blute ML, Zincke H: Critical evaluation of salvage surgery for radio-recurrent/ resistant prostate cancer. J Urol 154:1103-1109, 1995
41. Dillioglugil O, Leibman BD, Leibman NS, et al: Risk factors for complications and morbidity after radical retropubic prostatectomy. J Urol 157:1760-1767, 1997
42. Perrotte P, Litwin MS, McGuire EJ, et al: Quality of life after salvage cryotherapy: The impact of treatment parameters. J Urol 162:398-402, 1999
43. Izawa JI, Ajam K, McGuire E, et al: Major surgery to manage definitively severe complications of salvage cryotherapy for prostate cancer. J Urol 164:1978-1981, 2000
44. Leibovich BC, Izawa J, Zincke H, et al: Recurrent prostate cancer after radiation therapy: salvage prostatectomy versus salvage cryosurgery. J Urol 165:389, 2001 (abstr 1595)
45. Thompson IM, Tangen C, Basler J, et al: Impact of previous local treatment for prostate cancer on subsequent metastatic disease. J Urol 168:1008-1012, 2002